Galenical formulations of aliskiren and hydrochlorothiazide

Details for Australian Patent Application No. 2007263261 (hide)

Owner Novartis AG

Inventors Willmann, Matthias

Agent Davies Collison Cave

Pub. Number AU-B-2007263261

PCT Pub. Number WO2007/147596

Priority 0612540.5 23.06.06 GB

Filing date 21 June 2007

Wipo publication date 27 December 2007

Acceptance publication date 14 July 2011

International Classifications

A61K 9/20 (2006.01) Medicinal preparations characterised by special physical form - Pills, lozenges or tablets

A61K 31/165 (2006.01) - having aromatic rings, e.g. colchicine, atenolol, progabide

A61K 31/549 (2006.01) - having two or more nitrogen atoms in the same ring, e.g. hydrochlorothiazide

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/147596 Priority application(s): WO2007/147596

14 July 2011 Application Accepted

  Published as AU-B-2007263261

10 November 2011 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007263265-Differential IL-4 and/or IL-10 cytokine expression in human cancer

2007263248-Drive with an energy recovery function having a brake pressure control valve